TIGIT blockade repolarizes AML-associated TIGIT+ M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis
Background Leukemia-associated macrophages (LAMs) represent an important cell population within the tumor microenvironment, but little is known about the phenotype, function, and plasticity of these cells. The present study provides an extensive characterization of macrophages in patients with acute...
Saved in:
| Main Authors: | Friedrich Haag, Carsten Bokemeyer, Lars Bullinger, Franziska Brauneck, Brit Fischer, Marius Witt, Jana Muschhammer, Jennyfer Oelrich, Pedro Henrique da Costa Avelar, Sophia Tsoka, Elisa Seubert, Daniel J Smit, Christin Ackermann, Jasmin Wellbrock, Walter Fiedler |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-12-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/10/12/e004794.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expression of the TIGIT axis and the CD39/CD73 purinergic pathway in bone metastasis-derived immune cells
by: Elias Brauneck, et al.
Published: (2025-04-01) -
TIGIT blockade improves anti-Mycobacterium tuberculosis immunity
by: Jingyu Zhou, et al.
Published: (2025-06-01) -
Tiragolumab and TIGIT: pioneering the next era of cancer immunotherapy
by: Kosar Ghasemi, et al.
Published: (2025-06-01) -
TIGIT blockade improves anti-Mycobacterium tuberculosis immunity.
by: Jingyu Zhou, et al.
Published: (2025-06-01) -
Knockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic Fc-active TIGIT antibodies
by: Dean A Lee, et al.
Published: (2023-12-01)